RBRichard Bendall

Richard Bendall

*This is an algorithmically generated author record based on publicly available information.

Richard Bendall has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Harry Richard Dalton

    Gastrointestinal Unit, Royal Cornwall Hospital, Cornwall, United Kingdom

    4 shared publications
  • Abigail Bartlett

    European Centre for Environment and Human Health, University of Exeter Medical School, Environment and Sustainability Institute, Penryn Campus, TR10 9FE, UK

    1 shared publication
  • Daniel Padfield

    European Centre for Environment and Human Health, University of Exeter Medical School, Environment and Sustainability Institute, Penryn Campus, TR10 9FE, UK

    1 shared publication
  • F Keane

    Peninsula College of Medicine and Dentistry, Royal Cornwall Hospital, UK

    1 shared publication
  • G. Courtauld

    1 shared publication
  • H Dalton

    Peninsula College of Medicine and Dentistry, Royal Cornwall Hospital, UK

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    A comprehensive list of bacterial pathogens infecting humans

    by Abigail Bartlett, Daniel Padfield, Luke Lear, Richard Bendall, Michiel Vos

    There exists an enormous diversity of bacteria capable of human infection, but no up-to-date, publicly accessible list is available. Combining a pragmatic definition of pathogenicity with an extensive search strategy, we report 1513 bacterial pathogens known to infect humans described pre-2021. Of these, 73 % were regarded as established (have infected at least three persons in three or more references) and 27 % as putative (fewer than three known cases). Pathogen species belong to 10 phyla and 24 classes scattered throughout the bacterial phylogeny. We show that new human pathogens are discovered at a rapid rate. Finally, we discuss how our results could be expanded to a database, which could provide a useful resource for microbiologists. Our list is freely available and archived on GitHub and Zenodo and we have provided walkthroughs to facilitate access and use.


  • Autochthonous Hepatitis E in Developed Countries and HEV/HIV Coinfection

    by J. G. Hunter, R. Bendall, H. R. Dalton

    A novel hepatitis virus was long suspected as the cause of outbreaks of unexplained hepatitis with high maternal mortality in Asia. An outbreak of unexplained hepatitis in a Soviet military camp in Afghanistan led one investigator to ingest a pooled fecal extract from affected service personnel. This resulted in the discovery of the hepatitis E virus (HEV) in 1983. Subsequent studies showed that HEV was endemic in large parts of the developing world. Its incidence in industrialized nations was initially attributed to travel-related exposure. For many years after the discovery of HEV, it was considered a “new” virus, and of no relevance to developed countries. This perceived wisdom has proven to be hopelessly inaccurate. Human infections with HEV are not “new,” and are of considerable global importance, including in developed countries.


  • Open Access

    P63 Neurological sequelae of acute and chronic HEV genotype 3 infection

    by H Dalton, N Kamar, H R Dalton, R Bendall, F Keane, J M Peron, P Cintas, L Pruhomme, J M Mansuy, L Rostaing, et al.

    Introduction HEV is an emerging infection in the developed world. It differs from HEV endemic in developing countries as it is caused by HEV genotype 3, is thought to be a porcine zoonosis, has a predilection for middle aged/elderly males, and can cause chronic infection in the immunosuppressed. Neurological symptoms associated with HEV infection have been described in both developed and developing countries. However, to date, no systematic study of the neurological sequelae of HEV has been undertaken. Aim To describe the clinical and laboratory features of the neurological complications of HEV genotype 3 infection. Method Retrospective review of 126 patients with locally acquired acute and chronic HEV genotype 3 infection from two University Hospitals: Truro (UK) and Toulouse (France). Results Neurological complications were seen in 7/126 (5.5%) of patients with HEV. The neurological complications included inflammatory polyradiculopathy (n=3), Guillain-Barré Syndrome (n=1), bilateral brachial neuritis (n=1), encephalitis (n=1), ataxia/proximal myopathy (n=1). Three cases occurred during acute HEV infection in non-immunocompromised patients and four occurred in immunocompromised patients with chronic HEV infection (three transplant patients, and one HIV-positive patient). HEV RNA was detected in the cerebrospinal fluid (CSF) of all four patients with chronic HEV infection and neurological symptoms. In one of these cases unique HEV quasispecies were documented in the CSF. In patients with acute HEV who had neurological symptoms, HEV RNA was absent in the CSF (n=2). Follow-up was up to 4 years and neurological outcomes were: complete resolution (n=3), improvement with residual neurological deficit (n=3), no improvement (n=1). Conclusion Neurological symptoms are an emerging extra-hepatic manifestation of HEV infection. The pathophysiology is not understood, but HEV may be neurotropic, as unique HEV quasispecies were isolated from the CSF of one of our cases.


  • 973 HEV IGG SEROPREVALENCE IN PATIENTS WITH CHRONIC LIVER DISEASE IN SOUTHWEST ENGLAND

    by R.J. Ali, L. Farrington, V. Ellis, R.P. Bendall, G. Courtauld, H. Hussaini, H.R. Dalton

  • Open Access

    914 THE ROLE OF HEV TESTING IN DRUG INDUCED LIVER INJURY

    by H.J. Fellows, W. Stableforth, M. Joseph, P. Thurairajah, U. Warshow, S. Hazeldine, R. Remnarace, S. Ijaz, S.H. Hussaini, R.P. Bendall, et al.